The global Minimal Residual Disease (MRD) market is booming, projected to reach \$1.9B in 2025 and grow at a CAGR of 12.88% through 2033. Driven by advancements in NGS, PCR, and FISH technologies, this market offers lucrative opportunities for healthcare providers and investors. Learn about market drivers, restraints, and key players.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.